Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics.
暂无分享,去创建一个
P. Kwo | W. Kraft | M. Sulkowski | I. Jacobson | S. Gordon | M. Al-Ibrahim | E. Lawitz | E. Quirk | J. Rockstroh | Richard J. O. Barnard | N. Mobashery | L. Caro | P. Panorchan | J. Gress | B. Maliakkal | P. Hwang | Michelle Miller